IDiyas

For the Inventor, By the Inventor

Wilmington, MA, United States of America

Keith Earl Robison

USPTO Granted Patents = 15 

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 124(Granted Patents)


Company Filing History:

goldMedal15 out of 850 
 
Millennium Pharmaceuticals Limited
 patents

Years Active: 1999-2012

Loading Chart...
15 patents (USPTO):Explore Patents
1. 8211640 - Identification of a family of secreted proteins in vascular endothelium (2012-07-03),
2. 7485431 - Identification of a family of secreted proteins in vascular endothelium (2009-02-03),
3. 7482171 - Angiotensin converting enzyme homolog and uses therefor (2009-01-27),
4. 7258988 - Identification of a family of secreted proteins in vascular endothelium (2007-08-21),
5. 7083944 - Molecules of the card-related protein family and uses thereof (2006-08-01),
6. 6989363 - Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor (2006-01-24),
7. 6884771 - Angiotensin converting enzyme homolog and uses therefor (2005-04-26),
8. 6610497 - Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor (2003-08-26),
9. 6500628 - Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor (2002-12-31),
10. 6465232 - Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor (2002-10-15),
11. 6395889 - Nucleic acid molecules encoding human protease homologs (2002-05-28),
12. 6331427 - Protease homologs (2001-12-18),
13. 6309849 - Nucleic acid molecules encoding human kinase and phosphatase homologues and uses therefor (2001-10-30),
14. 6194556 - Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor (2001-02-27),
15. 5945307 - Isolated nucleic acid molecules encoding a G-protein coupled receptor (1999-08-31),

Title: Keith Earl Robison: Innovator in Vascular Biology

Introduction

Keith Earl Robison is a prominent inventor based in Wilmington, MA (US). He has made significant contributions to the field of vascular biology, particularly through his research on secreted proteins in vascular endothelium. With a total of 15 patents to his name, Robison's work has implications for various medical conditions.

Latest Patents

Robison's latest patents focus on the identification of a family of secreted proteins known as SCUBE molecules. These inventions relate to gene expression in vascular endothelial cells. Specifically, he has discovered a novel gene family that includes SCUBE1, SCUBE2, and SCUBE3, which can be expressed in endothelial cells. The SCUBE proteins may play a crucial role in the development of cardiovascular disease, hemostasis, thrombosis, inflammatory diseases, bone metabolism disorders, urinary bladder disorders, and breast disorders.

Career Highlights

Robison is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential impact on understanding and treating various vascular-related health issues.

Collaborations

Some of his notable coworkers include Susan Laurene Acton and Frank Hsieh, who have collaborated with him on various projects and research initiatives.

Conclusion

Keith Earl Robison's contributions to the field of vascular biology through his innovative patents and research are noteworthy. His discoveries regarding SCUBE proteins hold promise for advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…